Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

Diabetes Care

Volumn 22, Issue 1, 1999, Pages 99-111

  Shamoon, H ^a   Cleary, P ^a   Barnie, A ^a   Genuth, S ^a   Maffin, C ^a   Tamborlane, W ^a   Wesche, J ^a   Nathan, D ^a  

^a EDIC Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; LIPIDS; LIPOPROTEINS; LONGITUDINAL STUDIES; MALE; MEDICAL HISTORY TAKING; OBESITY; QUALITY OF LIFE; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 0032958316     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.1.99     Document Type: Article

References (50)

1. Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 8:S23-S29, 1991
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Decken T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983
3. DCCT Research Group: The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. N Engl J Med 329:977-986, 1993
4. DCCT Research Group: Prevention of neuropathy: the effect of intensive diabetes therapy on the development and progression of neuropathy in the DCCT. Ann Intern Med 122:564-568, 1995
5. DCCT Research Group: Effect of intensive therapy on the development of diabetic nephropathy in the DCCT. Kidney Int 47:1703-1720, 1995
6. DCCT Research Group: The effect of intensive diabetes management on macrovascular events and risk factors in the DCCT. Am J Cardiol 75:894-903, 1995.
7. EDIC Data Coordinating Center: Epidemiology of Diabetes Interventions and Complications Protocol and Manual of Operations. Washington, DC, Biostatistics Center. The George Washington University, 1995
8. Stevens MJ, Edwards ME, Foster AVM, Watkins PJ: Selective neuropathy and pressured vascular response in the diabetic charcot foot. Diabetologia 35:148-154, 1992
9. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289, 1994
10. ETDRS Research Group: Grading diabetic retinopathy from stereotopic color fundus photographs: an extension of the modified Airlie House Classification: ETDRS report No. 100. Ophthalmology 98:786-806, 1991
11. Abt K: Problems of repeated significance testing. Controlled Clin Trials 1:377-381, 1981
12. Cox DR: Regression models and life tables. J R Stat Soc Series B 34:187-220, 1972
13. Tumbull BW: The empirical distribution function with arbitrarily grouped, censored, and truncated data. J R Stat Soc Series B 38:290-295, 1976
14. Finkelstein DM: A proportional hazards model for interval-censored failure time data. Biometrics 42:845-854, 1986
15. Lachin JM, Wei LJ: Estimators and tests in the analysis of nonindependent 2x2 tables with partially missing observations. Biometrics 44:513-528, 1988
16. Zeger SL, Liang K: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986
17. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38: 963-974, 1982.
18. McCullogh P, Nelder JA: Generalized Linear Models. 2nd ed. New York, Chapman & Hall, 1982
19. Fleming TR, Harrington DP: Counting Processes and Survival Analysis, New York, John Wiley, 1991
20. Breslow NE, Day NE: Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies. Lyon, France, International Agency for Research in Cancer (London, Oxford University Press), 1987
21. Klein R, Klein BEK, Moss SE, Davis, MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 107:237-243, 1989
22. DCCT Research Group, Klein R, Moss S: A comparison of the study populations in the Diabetes Control and Complications Trial (DCCT) and the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Arch Intern Med 155:745-754, 1995
23. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
24. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59: 750-755, 1987
25. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Decken T: Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144-148, 1987
26. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219-226, 1989
27. Fisher BM, Gillen G, Lindop GBM, Dargie HJ, Frier BM: Cardiac function and coronary arteriography in asymptomatic type 1 (insulin-dependent) diabetic patients: evidence for a specific diabetic hean disease. Diabetologia 29:706-712, 1986
28. Koistinen MJ: Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301:92-95, 1990
29. Gerson MC, Khoury JC, Hertzberg VS, Fischer EE, Scott RS: Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: results of an 8-year follow-up study. Am Heart J 116: 820-826, 1988
30. Persson G: Exercise tests in male diabetics. Acta Med Scand Suppl 305:7-23, 1977
31. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LEL, Jensen-Urstand MT: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253-1258, 1996
32. Palumbo PJ, Melton LJ: Peripheral vascular disease and diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. 1995 (NIH publ. no. 95-1468)
33. Riccardi G, Vaccaro O, Riveliese A, Romano G, Cambri V, Rubba P, Pauciullo P, Greco G, Iovine L, Mancini M: Association between retinopathy and impaired peripheral arterial circulation in insulin dependent diabetic patients. Arteriosclerosis 8:509-514, 1988
34. Carter SA: Clinical measurement of systolic pressures in limbs with arterial occlusive disease. JAMA 207:1869-1874, 1969
35. Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before the age of 31. Diabetologia 14:63-70, 1978.
36. Entmacher PS, Root HF, Marks HH: Longevity of diabetic patients in recent years. Diabetes 13:373-377, 1964
37. Riley WA, Bames RW, Bond MG, Evans G, Chambless LE, Heiss G: High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimag 1:168-172, 1991
38. Zinman B, Cleary P, O'Leary D, Orchard T, for the EDIC Study Group: The effect of intensive diabetes treatment on carotid artery wall thickness in the Epidemiology of Diabetes Interventions and Complications (Abstract). Diabetes 45 (Suppl. 2):188A, 1996
39. Rand LI, Krolewski AS, Aiello LM, Warram JH, Barker RS, Maki T: Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 313: 1433-1438, 1985
40. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR: Risk of proliferate diabetic retinopathy in juvenile-onset type 1 diabetes: a 40-yr follow-up study. Diabetes Care 9:443-452, 1986
41. Janka HU, Warram JH, Rand LI, Krowlewski AS: Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 38:460-464, 1989
42. Winocour PH, Durrington PK, Ishola M, Anderson DC, Cohen H: Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin-dependent diabetes mellitus. BMJ 294:1648-1651, 1987
43. Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI. Turner RC, Morris PJ: Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes 31:226-231, 1982
44. Cruickshanks KJ, Vadheim CM, Moss SE, Roth M-P, Riley WJ, Maclaren NK, Langfield D, Sparkes RS, Klein R, Rotter JI: Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes 41:879-885, 1992
45. The Diabetes Control and Complications Tnal Research Group: Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes 46:1829-1839, 1997
46. Holme I: Extension of clinical trials: 10 1/2 year follow-up of the Multiple Risk Factor Intervention Trial. Circulation 82:1857-1858, 1990
47. Kannel WB: Coronary Artery Surgery Study revisited: limitation of the intent-to-treat principle. Circulation 82:1859-1862, 1990
48. Canner PL, Berge KG, Wenger NK, Stamler J, Freedman L, Prineas RJ, Friedewald W, for the Coronary Drug Research Group: Fifteen year mortality in coronary drug project patients: long term benefit with niacin. J Am Coll Cardiol 8:1244-1245, 1986
49. Najjar MF, Rowland M: Anthropometric reference data and prevalence of overweight, United States, 1976-1980. United Health Stat 11:1987, No. 230
50. Hiatt WR, Marshall JA, Baxter J, Sandoval R, Hildebrandt W, Kahn LR, Hamman RF: Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol 43:597-606, 1990